Immix Biopharma, Inc.IMMXNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank45
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P45
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q3 2025-9.09%
Q2 2025-46.67%
Q1 202511.76%
Q4 202429.17%
Q3 2024-60.00%
Q2 202431.82%
Q1 202415.38%
Q4 2023-13.04%
Q3 20234.17%
Q2 2023-33.33%
Q1 202337.93%
Q4 2022-163.64%
Q3 20220.00%
Q2 2022-14.23%
Q1 202296.79%
Q4 2021-5257.14%
Q3 2021-135.29%
Q2 202180.17%
Q1 2021-20.00%
Q4 2020-549.35%
Q3 202060.91%
Q2 20200.00%
Q1 20200.00%